To determine the signaling pathways involved in the anti-fibrotic effect of ZLD1039, we focused on the Hippo signaling pathway, particularly due to the pivotal role of LATS1 as a key tumor suppressor within this pathway. This evidence concerns the gene LATS1 and neoplasm.